Multi-Omics Patient Subtyping: Unveiling Hidden Patterns in Biological Data

What Multi-Omics Patient Subtyping Is

Multi-omics patient subtyping is a sophisticated analytical approach that integrates various types of biological data, such as genomics (DNA sequences), transcriptomics (RNA expression levels), and proteomics (protein abundances) to identify distinct patient subgroups. This method leverages the rich information contained in these different layers of molecular data to reveal hidden patterns and relationships among patients.

The technique employs a 2D joint non-negative matrix factorization (NMF) algorithm, which decomposes high-dimensional datasets into lower-dimensional representations while preserving the non-negativity constraints inherent in biological measurements. This allows for the identification of latent factors that capture shared molecular signatures across different omics layers.

Why 2D Joint NMF Matters

The use of 2D joint NMF is crucial because it enables the simultaneous analysis of multiple omics data types, providing a comprehensive view of patient heterogeneity. By integrating genomics, transcriptomics, and proteomics, researchers can uncover complex biological mechanisms that might be missed when analyzing each layer in isolation.

Moreover, this method helps in identifying subgroups of patients with similar molecular profiles, which is essential for personalized medicine strategies, where treatments are tailored to specific patient subtypes based on their unique molecular characteristics.

How It Works

The 2D joint NMF algorithm begins by representing the multi-omics data as a matrix, where rows correspond to patients and columns represent features (e.g., genes or proteins). The goal is to decompose this matrix into two lower-dimensional matrices: one that represents latent factors common across all omics layers, and another that captures the specific contributions of each layer. These latent factors are then used to cluster patients based on their shared molecular signatures.

The factor-space scatter plot visualizes these latent factors in a 2D space, allowing researchers to explore the relationships between different patient subgroups and identify potential biomarkers or therapeutic targets.

Real-World Applications

Multi-omics patient subtyping has numerous applications in precision medicine. For instance, it can be used to stratify cancer patients into distinct subtypes based on their molecular profiles, which may influence treatment response and prognosis. This approach also aids in the discovery of novel biomarkers for disease diagnosis and monitoring.

In addition, this technique is valuable for understanding complex diseases like diabetes or Alzheimer's, where multiple omics layers can provide insights into the underlying biological mechanisms driving the disease progression.

Frequently asked questions

Try it live

Everything above runs in your browser — open Multi-Omics Patient Subtyping — 2D Joint NMF and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.